Jinling Pharmaceutical Co Ltd
SZSE:000919
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jinling Pharmaceutical Co Ltd
Total Current Liabilities
Jinling Pharmaceutical Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jinling Pharmaceutical Co Ltd
SZSE:000919
|
Total Current Liabilities
¥975.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Current Liabilities
¥4.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Current Liabilities
¥6.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
20%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Total Current Liabilities
¥12.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
11%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Total Current Liabilities
¥7.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Total Current Liabilities
¥2B
|
CAGR 3-Years
61%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Jinling Pharmaceutical Co Ltd
Glance View
Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 4,865 full-time employees. The Company’s main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The firm is also involved in the provision of medical services and the sale of medical instrument. The firm distributes its products in domestic market, with North China as its main market.
See Also
What is Jinling Pharmaceutical Co Ltd's Total Current Liabilities?
Total Current Liabilities
975.9m
CNY
Based on the financial report for Dec 31, 2025, Jinling Pharmaceutical Co Ltd's Total Current Liabilities amounts to 975.9m CNY.
What is Jinling Pharmaceutical Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
1%
Over the last year, the Total Current Liabilities growth was -5%. The average annual Total Current Liabilities growth rates for Jinling Pharmaceutical Co Ltd have been 4% over the past three years , 4% over the past five years , and 1% over the past ten years .
